The long-term goal of these studies is to identify biochemical steps unique to the transformed cell which might be amenable to interference by specific pharmacological agents. Experiments are proposed which will help unravel the cell's genetic and biochemical contributions to the process of neoplastic transformation induced by the viral oncogene v-src. Cancer is an intrinsically complex phenomenon which is poorly understood at the molecular level. The current lack of understanding at the molecular level has prevented such a directed pharmacological approach; commonly used drugs attack all dividing cells, limiting the dose employed and inducing serious side effects. Three particular sets of experiments are proposed: (1) experiments involving further characterization of the unique mutant allele v-src-L, and the subsequent manipulation of v-src-L by further mutation; (2) experiments to test the role of mitotic specific phosphorylations in the process of transformation by v-src; and (3) (in collaboration with Dr. Harold Varmus, UCSF) analysis of a unique set of mutant of v-src. v-src-L transforms chicken but not rat cells; it is host-range dependent for transformation. The pp60v-src-L protein encoded by v-src-L will be characterized in detail for the Km and Vmax of the intrinsic tyrosine- specific protein kinase activity against several substrates; preliminary evidence suggests it exhibits a host-dependent substrate specificity (a unique property among all oncogenes reported thus far). Proposed biochemical and genetic experiments will address how this host-dependent regulation is accomplished. Further experiments will identify the relevant chicken and rat cellular genes involved in this regulation. Site-directed mutagenesis will be used to analyze the necessity of mitosis- specific phosphorylation of wt pp60v-src for (a) increased kinase activity associated with pp60v-src during mitosis and (b) transformation by v-src. Work by others in this field has focused on pp60c-src. Finally, a collection of naturally occurring, biologically selected v-src alleles (generated by H. Varmus) will be analyzed with regard to sequence in order to search for domains of pp60v-src which are critical for transformation. This collection of mutants is unique in that each member is (a) naturally occurring (implying no investigator bias), and (b) a point mutant (implying a relatively subtle lesion).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA052791-04
Application #
3197639
Study Section
Pathology B Study Section (PTHB)
Project Start
1990-07-10
Project End
1995-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Pennsylvania State University
Department
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Nelle, T D; Verderame, M F; Leis, J et al. (1998) The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication. J Virol 72:1103-7
Verderame, M F (1997) pp60v-src transformation of rat cells but not chicken cells strongly correlates with low-affinity phosphopeptide binding by the SH2 domain. Mol Biol Cell 8:843-54
Verderame, M F; Nelle, T D; Wills, J W (1996) The membrane-binding domain of the Rous sarcoma virus Gag protein. J Virol 70:2664-8
Ignatoski, K M; Verderame, M F (1996) Lysis buffer composition dramatically affects extraction of phosphotyrosine-containing proteins. Biotechniques 20:794-6
Verderame, M F; Guan, J L; Woods Ignatoski, K M (1995) Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src. Mol Biol Cell 6:953-66
Shao, H; Lou, L; Pandey, A et al. (1995) cDNA cloning and characterization of a Cek7 receptor protein-tyrosine kinase ligand that is identical to the ligand (ELF-1) for the Mek-4 and Sek receptor protein-tyrosine kinases. J Biol Chem 270:3467-70
Verderame, M F; Varmus, H E (1994) Highly conserved amino acids in the SH2 and catalytic domains of v-src are altered in naturally occurring, transformation-defective alleles. Oncogene 9:175-82
Siever, D A; Verderame, M F (1994) Identification of a complete Cek7 receptor protein tyrosine kinase coding sequence and cDNAs of alternatively spliced transcripts. Gene 148:219-26
Woods, K M; Verderame, M F (1994) Autophosphorylation is required for high kinase activity and efficient transformation ability of proteins encoded by host range alleles of v-src. J Virol 68:7267-74